Free Trial
LON:OBI

Ondine Biomedical (OBI) Share Price, News & Analysis

Ondine Biomedical logo
GBX 8.21 -0.29 (-3.41%)
(As of 12/20/2024 10:19 AM ET)

About Ondine Biomedical Stock (LON:OBI)

Key Stats

Today's Range
8.21
8.50
50-Day Range
6
9
52-Week Range
4.50
11.40
Volume
338,178 shs
Average Volume
320,178 shs
Market Capitalization
£22.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection-based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces viral titres and transmission of respiratory viruses, such as SARS-CoV-2, influenza, RSV, etc.; a solution for treatment of chronic rhinosinusitis; a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.

Receive OBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter.

OBI Stock News Headlines

Ondine Commencing US Phase 3 Clinical Trial
Rare "crisis signal" triggers for third time in U.S. market
A rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the market crashed 78% (the dot-com bust) and 89% (the Great Depression). Today, according to one of America's leading experts (who has predicted nearly every financial crisis of the last 25 years), what's coming next could soon crash the market by 50% or more, and keep it down for 10, 20, or even 30 years.
Ondine Biomedical (LON:OBI) Trading 2% Higher - Here's Why
Ondine Continues Commercial Growth
See More Headlines

OBI Stock Analysis - Frequently Asked Questions

Ondine Biomedical's stock was trading at GBX 8.75 at the start of the year. Since then, OBI stock has decreased by 6.2% and is now trading at GBX 8.21.
View the best growth stocks for 2024 here
.

Shares of OBI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ondine Biomedical investors own include AutoZone (AZO), Intel (INTC), Premier African Minerals (PREM), Rolls-Royce Holdings plc (RR), TJX Companies (TJX), Abacus Health Products (ABAHF) and Aurora Cannabis (ACB).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
£-14,270,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.63 million
Cash Flow
GBX 4.12 per share

Miscellaneous

Free Float
N/A
Market Cap
£22.77 million
Optionable
Not Optionable
Beta
0.10
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (LON:OBI) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners